外泌体在非酒精性脂肪性肝病发生发展中的作用

徐昆; 石清兰; 胡振斌; 张旭; 李瑛

doi:10.3969/j.issn.1001-5256.2021.10.047

外泌体在非酒精性脂肪性肝病发生发展中的作用

DOI: 10.3969/j.issn.1001-5256.2021.10.047

徐昆¹,
石清兰^2, ,,
胡振斌²,
张旭¹,
李瑛¹

1.
广西中医药大学研究生院，南宁 530222
2.
广西中医药大学第一附属医院肝病一区，南宁 530023

基金项目:

国家自然科学基金 (82060847);

国家自然科学基金 (81760849);

广西自然科学基金面上项目 (2020JJA140365)

详细信息

通信作者:
石清兰，bshiqinglan@163.com

中图分类号: R575.5
计量
- 文章访问数: 498
- HTML全文浏览量: 85
- PDF下载量: 38
- 被引次数: 0
出版历程
- 收稿日期: 2021-02-18
- 录用日期: 2021-03-15
- 出版日期: 2021-10-20

Role of exosomes in the development and progression of nonalcoholic fatty liver disease

Kun XU¹,
Qinglan SHI^{2
, ,},
Zhenbin HU²,
Xu ZHANG¹,
Ying LI¹

1.
Graduate School of Guangxi University of Chinese Medicine, Nanning 530222, China
2.
First Ward of Hepatology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China

Research funding:

National Natural Science Foundation of China （82060847）

National Natural Science Foundation of China （81760849）

General Project of Natural Science Foundation of Guangxi Province （2020JJA140365）

摘要

摘要: 随着肥胖和2型糖尿病等代谢性疾病的发病率增加，非酒精性脂肪性肝病(NAFLD)的发病率也逐年升高。NAFLD的潜在发病机制复杂，现尚未完全阐明。外泌体作为细胞间通讯的载体，在肝脏疾病的发生发展中发挥着重要作用。总结了外泌体在NAFLD发病过程中的作用机制及其对脂质代谢、胰岛素抵抗、肝脏炎症和纤维化的影响。指出了外泌体在治疗和诊断疾病方面的巨大潜力。
- 外泌体 /
- 非酒精性脂肪性肝病 /
- 肝疾病
Abstract: With the increasing incidence rates of metabolic diseases such as obesity and type 2 diabetes, the incidence rate of nonalcoholic fatty liver disease (NAFLD) has also gradually increased year by year. NAFLD has complex underlying pathogeneses which have not yet been fully clarified. As the carrier of intercellular communication, exosomes play an important role in the development and progression of liver diseases. This article summarizes the mechanism of action of exosomes in the pathogenesis of NAFLD and their effect on lipid metabolism, insulin resistance, liver inflammation, and fibrosis, and it is pointed out that exosomes have great potential in the diagnosis and treatment of diseases, which will be the focus of future research.
- Exosomes /
- Non-Alcoholic Fatty Liver Disease /
- Liver Diseases

HTML全文

参考文献(36)

[1]	DORAIRAJ V, SULAIMAN SA, ABU N, et al. Extracellular vesicles in the development of the non-alcoholic fatty liver disease: An update[J]. Biomolecules, 2020, 10(11): 1494. DOI: 10.3390/biom10111494.
[2]	WU TF, LIAO XH, ZHONG BH. Epidemiology of nonalcoholic fatty liver disease in some regions of China[J]. J Clin Hepatol, 2020, 36(6): 1370-1373. DOI: 10.3969/j.issn.1001-5256.2020.06.039. 吴挺丰, 廖献花, 钟碧慧. 中国部分地区非酒精性脂肪肝病的流行情况[J]. 临床肝胆病杂志, 2020, 36(6): 1370-1373. DOI: 10.3969/j.issn.1001-5256.2020.06.039.
[3]	YOUNOSSI Z, TACKE F, ARRESE M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Hepatology, 2019, 69(6): 2672-2682. DOI: 10.1002/hep.30251.
[4]	CAI S, CHENG X, PAN X, et al. Emerging role of exosomes in liver physiology and pathology[J]. Hepatol Res, 2017, 47(2): 194-203. DOI: 10.1111/hepr.12794.
[5]	HERNÁNDEZ A, ARAB JP, REYES D, et al. Extracellular vesicles in NAFLD/ALD: From pathobiology to therapy[J]. Cells, 2020, 9(4): 817. DOI: 10.3390/cells9040817.
[6]	LU R, HONG TP. Roles of abnormal lipid metabolism in pathogenesis of non-alcoholic fatty liver disease[J]. J Clin Hepatol, 2015, 31(7): 1050-1054. DOI: 10.3969/j.issn.1001-5256.2015.07.013. 路然, 洪天配. 脂质代谢紊乱导致非酒精性脂肪性肝病的发病机制[J]. 临床肝胆病杂志, 2015, 31(7): 1050-1054. DOI: 10.3969/j.issn.1001-5256.2015.07.013.
[7]	LI Y, LUAN Y, LI J, et al. Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism[J]. Hepatol Int, 2020, 14(6): 1057-1074. DOI: 10.1007/s12072-020-10096-0.
[8]	WANG W, ZHU N, YAN T, et al. The crosstalk: Exosomes and lipid metabolism[J]. Cell Commun Signal, 2020, 18(1): 119. DOI: 10.1186/s12964-020-00581-2.
[9]	RONG B, FENG R, LIU C, et al. Reduced delivery of epididymal adipocyte-derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice[J]. J Pineal Res, 2019, 66(4): e12561. DOI: 10.1111/jpi.12561.
[10]	CHEN Y, SUN H, BAI Y, et al. Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice[J]. Biochem Biophys Res Commun, 2019, 509(3): 767-772. DOI: 10.1016/j.bbrc.2018.12.180.
[11]	ZHANG Y, YU M, DAI M, et al. miR-450a-5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP2[J]. J Cell Sci, 2017, 130(6): 1158-1168. DOI: 10.1242/jcs.197764.
[12]	DAI M, YU M, ZHANG Y, et al. Exosome-like vesicles derived from adipose tissue provide biochemical cues for adipose tissue regeneration[J]. Tissue Eng Part A, 2017, 23(21-22): 1221-1230. DOI: 10.1089/ten.TEA.2017.0045.
[13]	ZHONG QH, HUANG B, LU W, et al. Adipose stem cell-derived exosomes carry miR-27 to inhibit browning of white adipose[J]. Tianjin Med J, 2020, 48(3): 165-170. DOI: 10.11958/20192867. 钟琼慧, 黄波, 卢婉, 等. 脂肪干细胞来源外泌体携带miR-27抑制白色脂肪的棕色化[J]. 天津医药, 2020, 48(3): 165-170. DOI: 10.11958/20192867.
[14]	SONG M, HAN L, CHEN FF, et al. Adipocyte-derived exosomes carrying sonic hedgehog mediate m1 macrophage polarization-induced insulin resistance via Ptch and PI3K pathways[J]. Cell Physiol Biochem, 2018, 48(4): 1416-1432. DOI: 10.1159/000492252.
[15]	DENG ZB, POLIAKOV A, HARDY RW, et al. Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance[J]. Diabetes, 2009, 58(11): 2498-2505. DOI: 10.2337/db09-0216.
[16]	YUASA T, AMO-SHIINOKI K, ISHIKURA S, et al. Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling[J]. Diabetologia, 2016, 59(12): 2711-2721. DOI: 10.1007/s00125-016-4102-5.
[17]	KUMAR A, SUNDARAM K, MU J, et al. High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance[J]. Nat Commun, 2021, 12(1): 213. DOI: 10.1038/s41467-020-20500-w.
[18]	CHEN YH, HENEIDI S, LEE JM, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance[J]. Diabetes, 2013, 62(7): 2278-2286. DOI: 10.2337/db12-0963.
[19]	WEN F, YANG Y, JIN D, et al. MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells[J]. Biochem Biophys Res Commun, 2014, 445(2): 517-523. DOI: 10.1016/j.bbrc.2014.02.034.
[20]	XIE J, HAN ZM, YIN WL. The mechanism of miR-27a induced insulin resistance on 3T3-L1 adipocyte cells[J]. Anhui Med J, 2019, 23(12): 2378-2381. DOI: 10.3969/j.issn.1009-6469.2019.12.011. 谢军, 韩造木, 尹琬凌. 微RNA-27a介导3T3-L1脂肪细胞胰岛素抵抗的作用机制[J]. 安徽医药, 2019, 23(12): 2378-2381. DOI: 10.3969/j.issn.1009-6469.2019.12.011.
[21]	SU T, XIAO YZ, XIAO Y, et al. Bone marrow mesenchymal stem cells-derived exosomal MiR-29b-3p regulates aging-associated insulin resistance[J]. ACS Nano, 2019, 13(2): 2450-2462. DOI: 10.1021/acsnano.8b09375.
[22]	LI F, LI H, JIN X, et al. Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release[J]. Cell Cycle, 2019, 18(17): 2067-2082. DOI: 10.1080/15384101.2019.1638694.
[23]	TIAN F, TANG P, SUN Z, et al. MiR-210 in exosomes derived from macrophages under high glucose promotes mouse diabetic obesity pathogenesis by suppressing NDUFA4 expression[J]. J Diabetes Res, 2020, 2020: 6894684. DOI: 10.1155/2020/6894684.
[24]	PAN Y, HUI X, HOO R, et al. Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation[J]. J Clin Invest, 2019, 129(2): 834-849. DOI: 10.1172/JCI123069.
[25]	ZHAO Z, ZHONG L, LI P, et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p[J]. Exp Cell Res, 2020, 387(1): 111738. DOI: 10.1016/j.yexcr.2019.111738.
[26]	LIU XL, PAN Q, CAO HX, et al. Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through Rictor/Akt/Forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease[J]. Hepatology, 2020, 72(2): 454-469. DOI: 10.1002/hep.31050.
[27]	HIRSOVA P, GORES GJ. Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis[J]. Cell Mol Gastroenterol Hepatol, 2015, 1(1): 17-27. DOI: 10.1016/j.jcmgh.2014.11.005.
[28]	KAKAZU E, MAUER AS, YIN M, et al. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner[J]. J Lipid Res, 2016, 57(2): 233-245. DOI: 10.1194/jlr.M063412.
[29]	ZEHRA M, CURRY JC, PILLAI SS, et al. Elucidating potential profibrotic mechanisms of emerging biomarkers for early prognosis of hepatic fibrosis[J]. Int J Mol Sci, 2020, 21(13): 4737. DOI: 10.3390/ijms21134737.
[30]	KIM JH, LEE CH, LEE SW. Exosomal transmission of microRNA from HCV replicating cells stimulates transdifferentiation in hepatic stellate cells[J]. Mol Ther Nucleic Acids, 2019, 14: 483-497. DOI: 10.1016/j.omtn.2019.01.006.
[31]	CHEN L, YAO X, YAO H, et al. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells[J]. FASEB J, 2020, 34(4): 5178-5192. DOI: 10.1096/fj.201902307RRR.
[32]	LIU R, LI X, ZHU W, et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis[J]. Hepatology, 2019, 70(4): 1317-1335. DOI: 10.1002/hep.30662.
[33]	FANG PP, PAN CW, LIN W, et al. ASK1 enhances angiotensin Ⅱ-Induced liver fibrosis in vitro by mediating endoplasmic reticulum stress-dependent exosomes[J]. Mediators Inflamm, 2020, 2020: 8183713. DOI: 10.1155/2020/8183713.
[34]	CSAK T, BALA S, LIPPAI D, et al. MicroRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis[J]. Liver Int, 2015, 35(2): 532-541. DOI: 10.1111/liv.12633.
[35]	LI CJ, FANG QH, LIU ML, et al. Current understanding of the role of adipose-derived extracellular vesicles in metabolic homeostasis and diseases: Communication from the distance between cells/tissues[J]. Theranostics, 2020, 10(16): 7422-7435. DOI: 10.7150/thno.42167.
[36]	WAN K, ZHANG Y, LIN Q, et al. Serum exosome microRNA-218 expression level and prognosis of liver cancer[J]. Traum Crit Med, 2020, 8(4): 286-289, 293. DOI: 10.16048/j.issn.2095-5561.2020.04.18. 万科, 张易, 林强, 等. 血清外泌体微小核糖核酸-218表达水平与肝癌预后研究[J]. 创伤与急危重病医学, 2020, 8(4): 286-289, 293. DOI: 10.16048/j.issn.2095-5561.2020.04.18.